116 related articles for article (PubMed ID: 10500777)
1. Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
Elgie AW; Sargent JM; Williamson CJ; Lewandowicz GM; Taylor CG
Adv Exp Med Biol; 1999; 457():29-33. PubMed ID: 10500777
[TBL] [Abstract][Full Text] [Related]
2. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
[TBL] [Abstract][Full Text] [Related]
3. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.
Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Witz F; Rose C; Guerci O
Blood; 1995 Apr; 85(8):2147-53. PubMed ID: 7536492
[TBL] [Abstract][Full Text] [Related]
4. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
[TBL] [Abstract][Full Text] [Related]
5. A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia.
Hedley DW; Xie SX; Minden MD; Choi CH; Chen H; Ling V
Leukemia; 1997 Jan; 11(1):48-53. PubMed ID: 9001418
[TBL] [Abstract][Full Text] [Related]
6. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study.
Ivy SP; Olshefski RS; Taylor BJ; Patel KM; Reaman GH
Blood; 1996 Jul; 88(1):309-18. PubMed ID: 8704189
[TBL] [Abstract][Full Text] [Related]
7. Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.
Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Wessels H; de Witte T
Blood; 1999 Oct; 94(7):2414-23. PubMed ID: 10498614
[TBL] [Abstract][Full Text] [Related]
8. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).
Tang R; Faussat AM; Perrot JY; Marjanovic Z; Cohen S; Storme T; Morjani H; Legrand O; Marie JP
BMC Cancer; 2008 Feb; 8():51. PubMed ID: 18271955
[TBL] [Abstract][Full Text] [Related]
9. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M; Turzanski J; Langabeer S; Russell NH
Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides.
Motomura S; Motoji T; Takanashi M; Wang YH; Shiozaki H; Sugawara I; Aikawa E; Tomida A; Tsuruo T; Kanda N; Mizoguchi H
Blood; 1998 May; 91(9):3163-71. PubMed ID: 9558371
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
12. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
[TBL] [Abstract][Full Text] [Related]
13. New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.
Takeshita A; Shinjo K; Ohnishi K; Ohno R
Jpn J Cancer Res; 1995 Jun; 86(6):607-15. PubMed ID: 7622426
[TBL] [Abstract][Full Text] [Related]
14. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
Mülder HS; Dekker H; Pinedo HM; Lankelma J
Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
[TBL] [Abstract][Full Text] [Related]
15. Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
Lautier D; Bailly JD; Demur C; Herbert JM; Bousquet C; Laurent G
Int J Cancer; 1997 Apr; 71(2):292-9. PubMed ID: 9139856
[TBL] [Abstract][Full Text] [Related]
16. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.
Tan SF; Dunton W; Liu X; Fox TE; Morad SAF; Desai D; Doi K; Conaway MR; Amin S; Claxton DF; Wang HG; Kester M; Cabot MC; Feith DJ; Loughran TP
J Lipid Res; 2019 Jun; 60(6):1078-1086. PubMed ID: 30962310
[TBL] [Abstract][Full Text] [Related]
17. Aphidicolin markedly increases the in vitro sensitivity to ara-C of blast cells from patients with AML.
Sargent JM; Elgie AW; Williamson CJ; Taylor CG
Adv Exp Med Biol; 1999; 457():567-70. PubMed ID: 10500835
[TBL] [Abstract][Full Text] [Related]
18. Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.
Legrand O; Simonin G; Perrot JY; Zittoun R; Marie JP
Adv Exp Med Biol; 1999; 457():161-75. PubMed ID: 10500791
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
Pallis M; Russell N
Blood; 2000 May; 95(9):2897-904. PubMed ID: 10779437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]